ArticleNeuro-oncology advances

Enhanced glioblastoma immunotherapy via SMAC mimetic dose escalation and TGFβ blockade.

Kyle Malone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.